Laurence Matthew Skelton net worth and biography

Laurence Skelton Biography and Net Worth

Insider of Vera Therapeutics

Matt Skelton is a seasoned biotech leader with extensive experience in driving global commercialization processes from development stages to successful launches. At Seagen, he scaled the commercial organization from a team of 9 to over 100, leading three successful product launches. His expertise spans global marketing, sales operations, market research, and forecasting, with a proven ability to lead cross-functional teams and develop strategic commercial plans. Prior to Seagen, Mr. Skelton held senior roles at Amgen, overseeing marketing and sales teams, and leading major product launches. He started his career at Eli Lilly as a sales representative. Matt holds a Bachelor of Arts degree from DePauw University.

What is Laurence Matthew Skelton's net worth?: The estimated net worth of Laurence Matthew Skelton is at least $2.62 million as of February 23rd, 2026. Skelton owns 64,218 shares of Vera Therapeutics stock worth more than $2,623,691 as of February 27th. This net worth estimate does not reflect any other assets that Skelton may own. Learn More about Laurence Matthew Skelton's net worth.
How do I contact Laurence Matthew Skelton?: The corporate mailing address for Skelton and other Vera Therapeutics executives is , , . Vera Therapeutics can also be reached via phone at 650-770-0077 and via email at [email protected]. Learn More on Laurence Matthew Skelton's contact information.
Has Laurence Matthew Skelton been buying or selling shares of Vera Therapeutics?: In the last ninety days, Laurence Matthew Skelton has sold $66,412.36 in shares of Vera Therapeutics stock. Most recently, Laurence Matthew Skelton sold 1,582 shares of the business's stock in a transaction on Monday, February 23rd. The shares were sold at an average price of $41.98, for a transaction totalling $66,412.36. Following the completion of the sale, the insider now directly owns 64,218 shares of the company's stock, valued at $2,695,871.64. Learn More on Laurence Matthew Skelton's trading history.
Who are Vera Therapeutics' active insiders?: Vera Therapeutics' insider roster includes Patrick Enright (Director), Marshall Fordyce (Founder), Marshall Fordyce (CEO and Founder), Sean Grant (CFO), David Johnson (COO), Maha Katabi (Director), Beth Seidenberg (Director), Laurence Skelton (Insider), and Joseph Young (CAO). Learn More on Vera Therapeutics' active insiders.
Are insiders buying or selling shares of Vera Therapeutics?: In the last year, Vera Therapeutics insiders bought shares 3 times. They purchased a total of 255,882 shares worth more than $5,527,583.36. In the last year, insiders at the sold shares 8 times. They sold a total of 48,490 shares worth more than $1,841,810.20. The most recent insider tranaction occured on February, 23rd when insider Robert Brenner sold 2,151 shares worth more than $90,298.98. Insiders at Vera Therapeutics own 16.3% of the company. Learn More about insider trades at Vera Therapeutics.
Information on this page was last updated on 2/23/2026.

Laurence Matthew Skelton Insider Trading History at Vera Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
2/23/2026	Sell	1,582	$41.98	$66,412.36	64,218

Laurence Matthew Skelton Buying and Selling Activity at Vera Therapeutics

Vera Therapeutics Company Overview

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase III clinical trial for patients with immunoglobulin A nephropathy; and for treatment of lupus nephritis that is in Phase II clinical trial. It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.

Today's Range

Now: $40.73

$40.26

$41.71

50 Day Range

MA: $46.53

$40.95

$55.26

2 Week Range

Now: $40.73

$18.53

$56.05

Volume

805,193 shs

Average Volume

1,038,916 shs

Market Capitalization

$2.85 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.16